Datasheet

Acinetobacter baumanniiΔPLDA (CAT#: LBGF-0126-GF80)

This is a weakened version of a common "superbug" found in hospitals. By removing a specific enzyme, the bacterium's ability to maintain its outer protective layer is compromised.

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

General Information Documents Customer Reviews Related Products Inquiry
Product Information
Product Overview This is a weakened version of a common "superbug" found in hospitals. By removing a specific enzyme, the bacterium's ability to maintain its outer protective layer is compromised.
Target Acinetobacter baumannii
Applications Used to identify new drug targets against drug-resistant infections. The advantage is that this strain is more sensitive to antibiotics and host immune components than the wild-type pathogen.
Product Identity & Gene Details
Chassis Strain Acinetobacter baumannii
Target Gene(s) PLDA
Gene Function PLDA encodes an outer membrane phospholipase A; it is responsible for breaking down phospholipids that end up in the wrong part of the membrane.
Modification Type Single gene knockout (Membrane integrity)
Genetic Architecture
Promoter System Native promoter
Selection Marker Standard Antibiotic Marker or Markerless/Scarless (No resistance genes)
Delivery & Service Standards
Deliverables Glycerol Stocks
Shipping Conditions Dry Ice Shipping
Lead Time 4-8 weeks
Documents Certificate of Analysis (COA) or Project Report
Verification PCR Sequencing
Engineered Strain Recovery & Handling
Immediate Post-Delivery Steps 1. Transfer to Storage: Immediately transfer the cryovials to a -80°C ultra-low temperature freezer.
2. Avoid Fluctuations: Do not store the vials in a "frost-free" freezer, as the temperature cycles can damage the cell membranes of the engineered strains.
Strain Recovery Protocol To ensure maximum viability, follow this standard recovery procedure:
1. Preparation: Prepare the appropriate selective agar medium (e.g., LB agar + specific antibiotic as listed in the COA).
2. Partial Thawing (The "Scratch" Method): * Place the cryovial on dry ice. Do not thaw the entire vial. Use a sterile inoculation loop or pipette tip to "scratch" a small amount of ice from the surface of the frozen stock.
3. Streaking: Streak the cells onto the selective agar plate to obtain single colonies.
4. Incubation: Invert the plate and incubate at the specified temperature (e.g., 37°C for E. coli or 30°C for S. cerevisiae) for 16-24 hours.
5. Subculturing: Pick a single, well-isolated colony to inoculate into liquid media for your experiments.
Usage Precautions & Best Practices
Antibiotic Pressure 1. Maintenance: For strains containing plasmids or specific resistance markers, always use the correct concentration of antibiotics in both solid and liquid media to prevent plasmid loss or contamination.

2. Markerless Strains: If the strain is a "scarless" integrated knockout, antibiotic pressure is not required for maintenance, but periodic genotypic verification is recommended.
Induction Conditions 1. If your strain uses an inducible promoter (e.g., T7/IPTG or Arabinose), ensure the culture reaches the optimal OD600 (typically 0.6-0.8) before adding the inducer.
2. Verify the optimal induction temperature, as engineered strains often produce better results at lower temperatures (e.g., 16-25°C) to prevent inclusion body formation.
Disposal All waste (vials, tips, plates) must be autoclaved at 121°C for at least 20 minutes or chemically disinfected before disposal.

Click the button below to contact us or submit your feedback about this product.


Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Creative Biolabs-Live Biotherapeutics


ISO 9001 Certified - Creative Biolabs Quality Management System.
Contact us

Copyright © 2026 Creative Biolabs. All Rights Reserved.

Inquiry Basket